Biological
GEN-003 clinical trials
Also written GEN-003.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Genocea Biosciences, Inc. (5)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses GEN-003 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionTerminatedPhase 2Genocea Biosciences, Inc.NCT03146403Written as GEN-003
- Safety and Immunogenicity Study of Therapeutic HSV-2 VaccineCompletedPhase 1/2Genocea Biosciences, Inc.NCT01667341Written as GEN-003
- Evaluating New Formulation of Therapeutic HSV-2 VaccineCompletedPhase 2Genocea Biosciences, Inc.NCT02515175Written as GEN-003
- Dose Ranging Safety and Efficacy of Therapeutic HSV-2 VaccineCompletedPhase 2Genocea Biosciences, Inc.NCT02114060Written as GEN-003 Vaccine (30μg of each antigen)
- Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 StudyCompletedPhase 2Genocea Biosciences, Inc.NCT02300142Written as GEN-003 Vaccine (30μg of each antigen)